Ambrosia Biosciences
CO - Boulder
BiotechnologyFocus: Oral Small Molecules - Class B GPCRs
Ambrosia Biosciences is a life sciences company focused on Oral Small Molecules - Class B GPCRs.
Gastroenterology
Funding Stage
PUBLIC
Total Funding
$130M
Open Jobs
0
Pipeline & Clinical Trials
Probiotics-Bio-plus
Liver CirrhosisClinical Trials (1)
NCT00312910Probiotics for the Prevention of Major Complications of Cirrhosis
N/ASolgar No7 Complex
Osteoarthritis, KneeClinical Trials (1)
NCT03442153Comparative Efficacy and Tolerability of No7 in Osteoarthritis of the Knee
N/APlasma
AgingClinical Trials (1)
NCT02803554Young Donor Plasma Transfusion and Age-Related Biomarkers
N/ABio-25
Lactose IntoleranceClinical Trials (1)
NCT01593800The Effect of Probiotics on Lactose Intolerance
N/AProbiotic Arm
ConstipationClinical Trials (1)
NCT06959758Effects of Probiotics (BioKid LR - Contains Nine Different Species of Probiotics Bacteria Including L. Reuteri) in Children With Functional Constipation
Phase 4Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2018
Portfolio: 5 clinical trials